3D Printing In Personalized Drug Delivery

3D printing is set to revolutionise the development, manufacture and delivery of vaccines and therapeutics; enabling patient-centric, personalised medicine and driving the digital transformation of healthcare. In this article, published in the American Pharmaceutical Review, CoM3D’s Chief Scientific Advisor A. Professor Mo Maniruzzaman, discusses the paradigm shift in the way we approach treatment options for patients and highlights the developments and advancements in patient-specific drug delivery systems.

16th March, 2021